huntington’s disease

Showing 3 posts of 3 posts found.

Roche's building

Roche’s Huntington’s disease treatment disappoints in Phase III trial

March 23, 2021
Manufacturing and Production Huntington's, Phase III trial, Roche, huntington's disease, tominersen

Roche has discontinued dosing in a Phase III trial of its tominersen treatment for Huntington’s disease, following discouraging initial data.


Blood biomarker found to track development of Huntington’s disease

June 8, 2017
Research and Development UCL, huntington's disease

Huntington’s disease (HD) is a rare and incurable hereditary condition of the central nervous system. The condition can cause involuntary …


Wave Life Sciences granted FDA orphan drug designation for Huntington’s disease drug

June 22, 2016
Research and Development FDA, drug, huntington's disease, wave life sciences

Wave Life Sciences (NASDAQ: WVE) has announced that it has received orphan drug designation for the US Food and Drug …

Latest content